(Total Views: 810)
Posted On: 01/04/2024 9:22:23 PM
Post# of 156076
As far as I understand Leronlimab doesn’t replicate in the body.
As for the ‘blimps’ say you had your last leronlimab dose 5 days ago, any new T-cell CCR5 receptors have a chance of there being not sufficient leronlimab to attach to them hence any infection or even re-enabled HIV cell can take advantage of the vulnerable CCR5 receptors to attach, highjack and replicate until your next dose attaches to any available CCR5 receptors to stop any further replication.
That’s my understanding, please feel free to correct me if my view is incorrect .
As for the ‘blimps’ say you had your last leronlimab dose 5 days ago, any new T-cell CCR5 receptors have a chance of there being not sufficient leronlimab to attach to them hence any infection or even re-enabled HIV cell can take advantage of the vulnerable CCR5 receptors to attach, highjack and replicate until your next dose attaches to any available CCR5 receptors to stop any further replication.
That’s my understanding, please feel free to correct me if my view is incorrect .
(3)
(0)
